RECURRENCE
Clinical trials for RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new RECURRENCE trials appear
Sign up with your email to follow new studies for RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Poop pills could stop deadly bile duct infections
Disease control Not yet recruitingThis study tests whether transplanting gut bacteria from healthy donors can prevent repeat episodes of a serious bile duct infection called cholangitis. About 44 adults who have had at least two infections in the past year will receive either fecal transplants or standard care. T…
Matched conditions: RECURRENCE
Phase: PHASE2 • Sponsor: Puerta de Hierro University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
AI may help decide who gets immunotherapy after liver cancer surgery
Disease control Not yet recruitingThis study will test whether a deep learning computer model can help doctors decide which liver cancer patients should receive immunotherapy (PD-1 inhibitors) after surgery to prevent the cancer from returning. About 300 patients who have had their liver cancer completely removed…
Matched conditions: RECURRENCE
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a common anesthetic keep lung cancer from returning?
Disease control Not yet recruitingThis study tests whether giving the anesthetic lidocaine during lung cancer surgery can reduce the chance of the cancer coming back. About 1,400 patients will be randomly assigned to receive lidocaine or a placebo. They will be followed for three years to track cancer recurrence …
Matched conditions: RECURRENCE
Phase: NA • Sponsor: First Affiliated Hospital of Ningbo University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Blood test may spot hidden breast cancer months before scans
Diagnosis Not yet recruitingThis study tests whether regular blood tests (ctDNA) can find triple-negative breast cancer recurrence earlier than standard follow-up. Thirty patients who had surgery for stage II or III TNBC will be randomly assigned to either standard care or standard care plus ctDNA testing e…
Matched conditions: RECURRENCE
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Blood test may predict liver cancer comeback and immunotherapy success
Knowledge-focused Not yet recruitingThis study looks at whether a blood test that detects tiny bits of tumor DNA (called minimal residual disease) can predict if liver cancer will come back after surgery. Researchers will test 276 patients before and after surgery to see if the test can also identify who might bene…
Matched conditions: RECURRENCE
Phase: NA • Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC